The inducible nonenzymatic chloramphenicol resistance (Cm') determinant of the IncP plasmid R26 was cloned on a 1,900-base-pair restriction endonuclease Hindlll fragment. Transposon TnS mutagenesis revealed that at least 1,400 base pairs is required for expression of Cmr. There was no increase in the level of Cmr when the copy number of the determinant was raised by cloning in pBR322 or pUBS572. Expression of Cmr by cells carrying a lower-copy-number pUBS572cml+ plasmid was inducible and thus indistinguishable from those with R26 itself. However, pBR322cml+-carrying cells expressed Cmr constitutively, possibly due to the activity of vector promoters or an elevated copy number. Transcriptional and translational cml-lac fusions were constructed. The operon (transcriptional) cml-lac fusion carried by the low-copy-number plasmid pUB5572 caused a low level of constitutive ,-galactosidase activity, which could not be elevated by induction with chloramphenicol and was not affected by a coresident R26cml+ element. In contrast, the gene (translational) cml-lac fusion expressed low-level l-galactosidase activity, which was elevated fivefold by prior exposure to chloramphenicol. We conclude that the regulation of Cmr occurs posttranscriptionally.
The most commonly encountered mechanism of chloramphenicol resistance (Cmr) in gram-negative bacteria is that mediated by the plasmid-encoded enzyme chloramphenicol acetyltransferase (CAT). This enzyme is expressed constitutively and results in inactivation of the drug by 3-0-acetylation, using acetyl coenzyme A as a cofactor (13, 16, 26, 29) .
Plasmids have been identified in gram-negative bacteria that confer Cmr by a mechanism which does not involve CAT (15, 20, 22, 23) . The Cmr determinant of the IncP plasmid R26 is of this type (15) . It differs from CAT-mediated Cmr determinants in that it specifies a low level of resistance. Also, it is inducible and does not involve drug inactivation or modification (15) . Furthermore, the ribosomes in Cmr cells are not resistant to inhibition by chloramphenicol in vitro (15) . It is thought that resistance is conferred by a chloramphenicol-specific permeability barrier acting at the level of the cell envelope (15) .
In this paper, we report the molecular cloning of the R26 Cmr determinant and the mapping of the gene(s) responsible for resistance by restriction enzyme analysis and by transposon TnS mutagenesis. Also, the mechanism of regulation was investigated by analyzing the properties of cml-lac gene and operon fusions.
MATERIALS AND METHODS Bacterial strains and plasmids. The Escherichia coli K-12 strains were C600 thr leu lac supE, XAc Su-A(lac-pro)XIII ara argE thi gyrA rpoB (both obtained from N. Kleckner, Harvard University), and J5-3 pro met (8) . The plasmids used are listed in Table 1 .
Bacteriological media, chemicals, and antibiotics. The compositions of L broth, L agar, and M9 minimal medium were previously described (14) . MacConkey agar (Oxoid Ltd.) was used for studying cml-lac fusions.
Antibodies and other inhibitors were incorporated into agar as follows (micrograms per milliliter): ampicillin (Beecham Laboratories), 50; chloramphenicol (Sigma Chemical Co.), 20; kanamycin (Sigma), 20 ; sulfathiazole (BDH), 20; tetracycline (Sigma), 10; trimethoprim (Wellcome Research Laboratories), 30.
Chemicals were purchased from Sigma or were the best grade available from BDH.
Restriction endonucleases and T4 DNA ligase were obtained from Boehringer Mannheim Biochemicals or New England Biolabs and were used according to the instructions of the manufacturer.
DNA manipulations. Plasmid DNA was purified from cleared lysates (7) by centrifugation in ethidium bromide-cesium chloride density gradients. A small-scale method was employed for rapid screening of transformants, etc. (9) . Agarose gel electrophoresis was performed as previously described (1) . DNA fragments were excised from agarose gels by freeze-thawing, followed by extraction in 0.5 M NaCl-1 mM EDTA-10 mM Tris-hydrochloride (pH 7.8).
MIC determinations. The procedures for measuring the level of resistance to chloramphenicol by plate MIC determinations and growth and challenge tests in broth have been previously described (10) .
TnS mutagenesis. Chloramphenicol-sensitive derivatives of pDU1246 were isolated after insertion of transposon Tn5 with X rex::TnS c1857 b221 029 P80 (obtained from N. Kleckner, Harvard University) as a vector (9) .
j3-Galactosidase assays. The method for measuring ,-galactosidase activity was described by Miller (21) . Cloning the R26 cml gene(s) in pBR322 and pUB5572. About 20 ,ug of plasmid R26 DNA was cleaved with EcoRI and ligated with EcoRI-cleaved pBR322. A chloramphenicol-resistant transformant was isolated which carried a plasmid with a 7,000-base-pair (bp) insertion in pBR322.
A 1,900-bp HindIII fragment from this element was then inserted into the HindIll site of pBR322 in both orientations, giving pDU1246 and pDU1247.
To lower the copy number of the cloned cml genes, the were constructed by ligating the purified 7,700-bp BamHI lac fragment of pMC903 (which carries the promoterless lacZ gene [5] ) with partially BamHI-cleaved pDU1246 DNA.
Transformants of XAcSu-which were Apr Cm' Lac' were obtained. Two clones were isolated that had the lac fragment inserted in the two possible orientations (pDU1290 and pDU1291) (Fig. 1) .
The copy number of the cml-lac fusions was reduced by cloning the 8.9-kilobase (kb) HindIII fragment (having the lac insert in cm!) into the HindIII site at pUB5572. These plasmids are called pDU1292 and pDU1293 (Fig. 1) .
A gene (translational) fusion was constructed by inserting the purified 6.8-kb BamHI fragment of pMC931 (5) plasmid R26 on a 1,900-bp Hindlll fragment which was inserted into the HindIlI site of pBR322, giving pDU1246 and pDU1247, and into the low-copy-number vector pUB5572, forming plasmids pDU1248 and pDU1249. The phenotypes conferred by the three chimeric plasmids in E. coli J5-3 were compared with that of R26 by plate MIC determinations and by broth growth and challenge tests ( Table 2, Fig. 2 ). The MIC conferred by the two pBR322cml plasmids was indistinguishable irrespective of whether the cultures had been induced by exposure to a subtoxic concentration of chloramphenicol or were uninduced (Table 2) . In contrast, the pUB5572cml plasmids appeared to express high-level resistance to chloramphenicol only after induction, in a similar fashion to the parental plasmid R26. This behavior was confirmed by the broth growth and challenge tests (Fig. 2) . Thus, the complete resistance determinant, including structural and regulatory regions, must be contained within the 1,900-bp HindIlI fragment.
The observation that Cmr expression by pBR322cml plasmids in MIC experiments was expressed constitutively (Table 2) was tested in the growth and challenge tests (Fig. 2 ).
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a The host used throughout was E. coli K-12 J5-3.
b Induction was with 1 pLg of chloramphenicol per ml added to exponentially growing cells 60 min before plating.
level of cml gene expression from the multiple copies or due to the influence of vector promoters (28) or both.
Mapping the chloramphenicol resistance region. A detailed restriction map of the 1,900-bp HindIlI fragment in plasmids pDU1246 and pDU1247 was constructed (Fig. 3) . To map the Cmr determinant more precisely, transposon TnS was inserted in pDU1246, and 25 independent Cms mutants were isolated. The site of each insertion was mapped by restriction enzyme analysis. The distribution of the insertions showed that at least 1,400 bp was required for expression of Cmr (Fig. 3) . All but one of the pBR322cml::TnS mutants was completely Cms ( Table 2 ). The deletions constructed by removing DNA from either side of the BamHI site (pDU1333 and pDU1334; Fig. 3 ) also conferred a Cms phenotype (Table 2) . One TnS insertion mutant (pDU1280) allowed expression of low-level Cmr (Table 2) . A possible explanation for this is that the Tn5 insertion has damaged the carboxy terminus of a resistance protein. This idea was supported by the observation that a deletion which removed DNA to the right of the PstI site (pDU1335) also expressed a low level of Cmr (Fig.  3 , Table 2 ). Assuming that the direction of transcription is from left to right (Fig. 3) , the damage to the cml gene caused by the deletion in pDU1335 would be more extensive than that of the Tn5 insertion in pDU1280. This is consistent with the observation that pDU1335 expressed a lower level of Cmr than pDU1280 ( Table 2) .
Construction of cml-lac fusions and studies on the mechanism of regulation. To investigate the mechanism of regulation of the inducible Cmr determinant, both gene (translational) and operon (transcriptional) cml-lac fusions were generated to allow expression of the lacZ gene from a cml promoter. In the case of operon fusions, the expression of Fig. 1 ). P-Galactosidase was expressed constitutively by both elements (Table 3) . However, since the expression of the Cmr phenotype by multicopy pBR322cml plasmids was not inducible by chloramphenicol (Table 2 , Fig. 2 ) and thus apparently not subject to normal regulation, it was considered prudent to examine the expresison of P-galactosidase under low-copy-number conditions. Thus, the cml-lac fusions were cloned from pDU1290 and pDU1291 into the low-copy-number vector pUB5572 (Fig. 1) . The resulting pUB5572cml-lac fusion derivatives pDU1292 and pDU1293 also expressed Pgalactosidase constitutively, albeit at lower levels than the pBR322-located fusions (Table 3 ). This level of 1B-galactosidase activity was not altered by the presence of the wild-type Cmr determinant of R26 which expresses inducible chloramphenicol resistance (Table 3 ). This indicates that any transcriptional regulatory functions were not lacking in the operon fusions. Indeed, there is no evidence that expression of the cml gene(s) is regulated at the level of transcription.
A lacZ gene-carrying fragment of DNA derived from pMC931 which lacks a promoter, ribosome-binding site, and translational initiation codon was inserted into the BamHI site located in the cml region of pDU1253. ,B-Galactosidase activity will be expressed only if a promoter, ribosome-binding site, and in-frame initiation codon are provided by cml.
Thus, a hybrid chloramphenicol-1-galactosidase protein will be formed. Insertions in both orientations in the BamHI site located in the cml gene of pDU1253 were isolated, forming pDU1294 and pDU1295, respectively. Only pDU1294 expressed detectable 1-galactosidase activity (Table 4) . Furthermore, the level of expression was increased fivefold after induction with chloramphenicol. This suggests that the regulation occurs at the level of translation. This induction occurred in the absence of a wild-type Cmr determinant, suggesting that autogenous control is not involved. No increase in 3-galactosidase activity was detected when the wild-type inducible Cmr determinant was also present on plasmid pDU1249 (pUB5572cml+). In fact, the absolute bInduction was with 1 ,ug of chloramphenicol per ml for 60 min before assay.
level of p-galactosidase expressed by the pDU1294cml-lacZ and pDU1249cml+ cells was lower than that expressed by pDU1294 alone. Also, the induction ratio was threefold in the heterozygous strains compared with the fivefold induction ratio observed in the pDU1294-carrying cells. In addition, the vector plasmid pUB5572 also reduced the level of ,-galactosidase expressed by pDU1294 (Table 3) . This may be due to an effect on the copy number of the pBR322-derived plasmid. This, combined with the presence of an induced wild-type Cmr determinant which is thought to prohibit entry of drug into the cytoplasm (15) , could cause the reduction in absolute levels of P-galactosidase and also the induction ratio seen in the heterozygous strain.
DISCUSSION
The IncP plasmid R26 specifies resistance to chloramphenicol by a mechanism that is inducible and which does not involve drug inactivation (15) . Here we describe the molecular cloning and a genetic analysis of the R26 Cmr determinant. The Cmr phenotype was not inducible when the determinant was carried by the multicopy plasmid pBR322. However, when the genes were transferred to the low-copy-number plasmid pUB5572, resistance was expressed inducibly. Thus, the 1,900-bp-HindIII fragment present in pDU1246, pDU1247, and pDU1249 is sufficient to encode the cml structural gene(s) and regulatory functions. Furthermore, TnS mutagenesis showed that at least 1,400 bp is required for Cmr (Fig. 3) .
The direction of transcription of the cml gene(s) can be inferred from the properties of a deletion mutant, pDU1335, and of a TnS insertion mutant, pDU1280, which express low-level Cmr (Table 2) , and also from the behavior of a cml-lacZ gene fusion. The simplest explanation for the low-level Cmr phenotype of the mutants is that the region encoding the carboxy terminus of a Cmr protein has been damaged. If this is the case, then transcription of the cml gene(s) must be from left to right as the map is drawn in Fig.  3 . The construction of a gene fusion between cml and lacZ (presumably resulting in the formation of a chloramphenicol-inducible hybrid chloramphenicol resistance-3-galactosidase protein) occurred only when the BamHI fragment from pMC931 which carries the lac operon was cloned in one particular orientation in the BamHI site located in cml.
Since P-galactosidase activity expressed by the fusion was inducible by chloramphenicol, it can be concluded that the protein is expressed from the cml promoter and that the direction of transcription is as indicated in Fig. 3 . The low level of P-galactosidase activity may be due to the fusion being out of frame. In this case, translational slippage would be responsible for the activity.
It seems likely that the cml promoter is quite weak. Operon fusions with lacZ located on a low-copy-number plasmid (eight copies per chromosome [5] ) expressed 20 U of 3-galactosidase. The higher activity of the pBR322cml-lac operon fusions (500 to 1,200 U) can be ascribed to the higher copy number of the plasmid (30 to 40 copies per chromosome (2, 3) combined with the activity of vector promoters, particularly in the case of pDU1290, where the strong outward-reading tet promoter of pBR322 could be involved (28) . However, despite the apparent weak transcription of the cml gene and the failure of preincubation with chloramphenicol to increase the rate even when a wild-type inducible Cmr determinant was present in the same cell, it is clear from resistance level determinations (Table 2 , Fig. 2 ) that a single copy of the cml gene on plasmid R26 is sufficient to confer the maximum achievable level of resistance on E. coli cells. Increasing the copy number of the cml gene(s) did not result in an increase in resistance level. Furthermore, the multicopy pBR322cml plasmids apparently expressed Cmr constitutively. Possibly, sufficient basal expression of the resistance determinant occurs to protect the cells from the inhibitory effect of the drug and to prevent induction.
Experiments with in vitro-constructed lac fusions have shed some light on the possible mechanism of regulation involved in the expression of Cmr. The operon (transcriptional) fusion was not induced by chloramphenicol under any circumstances, even when a low-copy-number plasmid carrying a wild-type inducible determinant was present in the same cell. This precludes the possibility that transcription of cml is being regulated either positively or negatively by a regulatory protein. Similarly, autogenous regulation of transcription by the Cmr protein is unlikely.
The data obtained with the cml-lac gene fusion indicate that induction occurs at the level of translation. Other systems in which translational regulation occurs include the ribosomal protein genes of E. coli (24, 25, 30) , gene 32 of bacteriophage T4 (19) , erythromycin resistance in gram-positive bacteria (17, 18) , and inducible Cmr mediated by CAT in Bacillus pumilus (11, 12) and Staphylococcus aureus (4) . Expression of the ribosomal protein operons of E. coli and gene 32 of T4 is controlled by a subtle interplay between the gene products and the message. These proteins are capable of binding to single-stranded nucleic acid molecules, the ribosomal proteins to rRNA, and the gene 32 product to single-stranded DNA. They can bind to specific regions of their own mRNA to modulate translation autogenously.
The regulation of erythromycin resistance involves the formation of alternative secondary structures in the mRNA 5' to the coding region for the resistance methylase. Ribosomes stalling in the presence of the drug cause conformational changes in the mRNA which exposes the hitherto sequestered ribosome-binding site for the methylase gene, thus permitting its translation. The expression of inducible CAT genes is thought to be controlled by a single secondary structure in the mRNA which sequesters the ribosome-binding site for the CAT gene. Induction by chloramphenicol may involve a chloramphenicol-mediated conformational change in 23S rRNA, permitting binding of the altered ribosome to that part of the message which is complementary to the CAT ribosome-binding site. This would leave the ribosome-binding site free to accept an unaltered ribosome to initiate translation (4) . Experiments are in progress to elucidate the nature of the translation regulation involved in the control of expression of the R26 cml gene.
